Undervalued Stocks Based On Cash Flows

Results

15

3 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

15 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
BEN
€6.51-5.8%-16.3%€524.8m€8.110.674.4%3.1%Consumer Durables
SWP
€29.80-3.7%-17.9%€283.5m€44.0014.817.5%6.7%Software
UBI
€5.164.8%-42.6%€708.0m€5.600.5120.5%n/aMedia
ALDMS
€1.27-2.3%5.0%€32.9m€2.200.671.8%n/aHealthcare
EXA
€104.00-1.0%16.5%€1.8b€152.43592.438.9%0%Capital Goods
ALSTI
€59.952.5%12.1%€301.2m€82.2626.221.3%1.1%Capital Goods
ANTIN
€9.160.2%-16.6%€1.6b€11.2115.313.3%7.8%Diversified Financials
AIR
€189.523.2%13.5%€149.1b€210.4429.815.7%1.7%Capital Goods
ABVX
€85.800.8%1,556.4%€6.8b€106.361389.863.6%n/aPharmaceuticals & Biotech
FII
New
€69.203.4%108.4%€3.1b€66.1950.029.8%0.7%Capital Goods
ERA
€49.22-7.1%7.1%€1.4b€54.800.5104.6%0%Materials
ALLOG
€1.75-3.3%-6.4%€19.5m€2.8215.733.8%n/aTech
EXENS
€59.151.4%37.2%€3.0b€67.1342.716.3%0.5%Capital Goods
ALKLK
New
€1.20-11.8%25.0%€8.6m€1.100.698.5%n/aTech
DIM
New
€161.90-7.7%-16.9%€15.9b€232.2158.820.9%0.4%Pharmaceuticals & Biotech
Page 1 of 1